Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. FFAI
9. TRMD
10. ACN

Go back to Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
(NASDAQ: TVTX) Delayed: 62.76 -1.98 (3.06%)
Previous Close $64.74    52 Week High $ 
Open $64.89    52 Week Low $ 
Day High $64.89    P/E N/A 
Day Low $62.47    EPS $ 
Volume 2,235,856